Upcoming Events

There are no upcoming events at this time.

Previous Events

April 10, 2021
Poster presentation: The differentiated CD47 monoclonal antibody AO-176 exhibits significant in vivo activity against xenograft models of pediatric acute lymphoblastic leukemia (ALL)
April 10, 2021
Poster presentation: AO-176, a highly differentiated clinical stage anti-CD47 antibody, is efficacious in pre-clinical models of lymphoma
December 6, 2020
Poster presentation: AO-176, a Highly Differentiated Clinical Stage Anti-CD47 Antibody, Exerts Potent Anti-Tumor Activity in Preclinical Models of Multiple Myeloma as a Single Agent and in Combination With Approved Therapeutics
December 5, 2020
Poster presentation: Pre-clinical Combination of AO-176, a Highly Differentiated Clinical Stage CD47 Antibody, with Either Azacitidine or Venetoclax Significantly Enhances DAMP Induction and Phagocytosis of Acute Myeloid Leukemia
December 7, 2019
Poster presentation: Highly Differentiated Anti-CD47 Antibody AO-176, Potently Inhibits Hematologic Malignancies Alone and in Combination in Pre-Clinical Models
November 8, 2019
Poster presentation: Novel SIRP Antibodies with Differentiated Characteristics for Targeting Innate Immunity in Cancer
March 31, 2019
Poster presentation: Evaluation of novel anti-SIRP antibodies as potential cancer therapeutics
March 31, 2019
Poster presentation: AO-176, a normal cell sparing humanized anti-CD47 antibody
December 1, 2018
Poster presentation: Therapeutic potential of AO-176, a next-generation humanized CD47 antibody, for hematologic malignancies